The healthcare sector around the world is compelled to address a host of challenges, ranging from the onset of a pandemic to the discovery of new drugs and treatments for different diseases and medical conditions. One of the major areas within the healthcare sphere that continues to attract immense attention is that of the rare neurodegenerative disease treatment and the growing prevalence of several rare diseases worldwide. In addition, the prevalence of the rare neurodegenerative diseases has witnessed a gradual growth over the past couple of decades, owing to surge in the aging population, fast-paced urban lifestyle, etc.
Research and development activities have played an imperative role in enabling the growth of the biomedical research space and informatics due to which, understanding the epigenetic modifications, nutrition, and microbiome impact on health has improved considerably. Technological advancements and availability of computational facilities for large-scale analysis have also played an essential role in fueling the growth of the rare neurodegenerative disease treatment market– a trend that is expected to continue during the forecast period. In addition, the emergence of new medical approaches and ongoing efforts to improve collaborative networks across healthcare facilities are other major factors that are likely to propel the growth of the rare neurodegenerative disease treatment market in the forthcoming decade.
Increasing government support, private investments toward the development of new treatments and therapeutics, and demand for personalized treatment programs is likely to deeply influence the growth trajectory of the market for rare neurodegenerative disease treatment in the upcoming years. At the back of these factors, the global rare neurodegenerative disease treatment market is expected to attain a market value of US$ 116.3 Bn by the end of 2030.
Over the past few decades, researchers, scientists, and other experts across the healthcare sector have come together to discover new therapies and medications for different rare neurodegenerative diseases. Research and development activities have shifted gears in the past decade due to which, the growth of the global rare neurodegenerative disease treatment market is projected to remain consistent in the upcoming years. In several regions, regulatory authorities, along with leading research organizations have enabled a host of research projects to move forward and thereby, offer promising advancements in the field of rare neurodegenerative disease treatment. For instance, the European Joint Programme on Rare Diseases (EJP RD) was primarily established to improve the overall efficiency and coordination among various research institutes working in tandem across the global rare neurodegenerative disease treatment market.
Research and development activities continue to focus on several key areas, including the development of novel therapeutics in a preclinical setting, leveraging disease models for improved drug development, and developing predictive and pharmacodynamics (PD) biomarkers in a preclinical setting. The overall growth of the global rare neurodegenerative disease treatment market is expected to be primarily driven by research and development activities. Although R&D activities have gained considerable momentum, market players are of the opinion that additional efforts and time are required to address several challenges across the rare diseases space.
The advent of the novel COVID-19 pandemic is anticipated to have a low impact on the overall growth of the global rare neurodegenerative disease treatment market. The healthcare bodies in different regions, along with local governments are increasingly seeking new approaches to address the medical conditions among patients suffering from rare diseases, including rare neurodegenerative diseases, as they are more vulnerable to the COVID-19 infection. Government personnel is increasingly focusing on providing access to high-quality and life-saving medications to patients suffering from rare diseases. While curbing the transmission of the novel COVID-19 virus is a top priority across the world, the U.S. FDA has also prioritized the development of new treatments for rare diseases. Moreover, governments in various developed regions of the world are also increasingly focusing on ensuring continuity of care for patients suffering from rare diseases such as global rare neurodegenerative disease. At present, governments across the world are seeking various avenues to improve the quality of treatment and access to these treatments for patients suffering from rare diseases during the COVID-19 pandemic.
Analysts’ Viewpoint
The global rare neurodegenerative disease treatment market is expected to expand at a moderate CAGR of ~5% during the forecast period. The market growth can be primarily attributed to factors such as growing prevalence of rare diseases worldwide, growing private investments, increasing support from governments, collaborations between research and medical institutes, and rising interest from the private sector. At present, research and development activities are likely to drive the global rare neurodegenerative disease treatment market.
Rare Neurodegenerative Disease Treatment Market – Segmentation
|
Indication |
|
|
Drug Class |
|
|
Distribution Channel |
|
|
Region |
|
Rare neurodegenerative disease treatment market is expected to attain a market value of US$ 116.3 Bn by 2030
Rare neurodegenerative disease treatment market is anticipated to expand at a CAGR of ~5% from 2020 to 2030
Rare neurodegenerative disease treatment market is driven by increase in incidence of neurological disorders
The multiple sclerosis (MS) segment dominated the global rare neurodegenerative disease treatment market and the trend is projected to continue during the forecast period
Key players in the global rare neurodegenerative disease treatment market include Allergan plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson
1. Executive Summary: Global Glycerol Carbonate Market
1.1. Global Glycerol Carbonate Market Volume (Kilo Tons) Forecast, 2019–2030
1.2. Global Glycerol Carbonate Market Value (US$ Mn) Forecast, by Region, 2019–2030
1.3. Trends Impacting Market
1.4. TMR’s Growth Opportunity Wheel
2. Market Overview
2.1. Glycerol Carbonate: Application Definitions
2.2. Glycerol Carbonate: End-use Definitions
2.3. Market Indicator
2.4. Market Dynamics
2.4.1. Drivers
2.4.2. Restraints
2.4.3. Key Opportunities
2.5. Porter’s Five Forces Analysis
2.6. Regulations
2.7. Value Chain Analysis
2.7.1. List of Manufacturers
2.7.2. List of Potential Customers
2.8. Regulatory Landscape
3. Market Outlook for Glycerol Carbonate-based Chemicals
3.1. Polycarbonate
3.2. Polyurethane
3.3. Polyamides
3.4. Polyesters
3.5. Glycidol
4. Impact of COVID-19 on Global Glycerol Carbonate Market
5. Production Output Analysis, 2019
6. Pricing Analysis
6.1. Pricing Analysis, by Region
7. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
7.1. Global Glycerol Carbonate Market Analysis, by Application, 2019–2030
7.1.1. Key Findings
7.2. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
7.2.1. Solvents
7.2.2. Fuel Additives
7.2.3. Monomers
7.2.4. Chemical Intermediates
7.2.5. Others
7.3. Global Glycerol Carbonate Market Analysis, by End-use, 2019–2030
7.3.1. Key Findings
7.4. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
7.4.1. Detergents
7.4.2. Cements
7.4.3. Fuels
7.4.4. Paints & Coatings
7.4.5. Plastics
7.4.6. Others
8. Global Glycerol Carbonate Market Analysis, by Region, 2019–2030
8.1. Key Findings
8.2. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Region, 2019–2030
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Glycerol Carbonate Market Attractiveness Analysis, by Region
9. North America Glycerol Carbonate Market Analysis
9.1. Key Findings
9.2. North America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
9.2.1. Solvents
9.2.2. Fuel Additives
9.2.3. Monomers
9.2.4. Chemical Intermediates
9.2.5. Others
9.3. North America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
9.3.1. Detergents
9.3.2. Cements
9.3.3. Fuels
9.3.4. Paints & Coatings
9.3.5. Plastics
9.3.6. Others
9.4. North America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country, 2019–2030
9.5. U.S. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
9.5.1. Solvents
9.5.2. Fuel Additives
9.5.3. Monomers
9.5.4. Chemical Intermediates
9.5.5. Others
9.6. U.S. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
9.6.1. Detergents
9.6.2. Cements
9.6.3. Fuels
9.6.4. Paints & Coatings
9.6.5. Plastics
9.6.6. Others
9.7. Canada Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
9.7.1. Solvents
9.7.2. Fuel Additives
9.7.3. Monomers
9.7.4. Chemical Intermediates
9.7.5. Others
9.8. Canada Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
9.8.1. Detergents
9.8.2. Cements
9.8.3. Fuels
9.8.4. Paints & Coatings
9.8.5. Plastics
9.8.6. Others
10. Europe Glycerol Carbonate Market Analysis
10.1. Key Findings
10.2. Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
10.2.1. Solvents
10.2.2. Fuel Additives
10.2.3. Monomers
10.2.4. Chemical Intermediates
10.2.5. Others
10.3. Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
10.3.1. Detergents
10.3.2. Cements
10.3.3. Fuels
10.3.4. Paints & Coatings
10.3.5. Plastics
10.3.6. Others
10.4. Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030
10.5. Germany Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
10.5.1. Solvents
10.5.2. Fuel Additives
10.5.3. Monomers
10.5.4. Chemical Intermediates
10.5.5. Others
10.6. Germany Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
10.6.1. Detergents
10.6.2. Cements
10.6.3. Fuels
10.6.4. Paints & Coatings
10.6.5. Plastics
10.6.6. Others
10.7. France Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
10.7.1. Solvents
10.7.2. Fuel Additives
10.7.3. Monomers
10.7.4. Chemical Intermediates
10.7.5. Others
10.8. France Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
10.8.1. Detergents
10.8.2. Cements
10.8.3. Fuels
10.8.4. Paints & Coatings
10.8.5. Plastics
10.8.6. Others
10.9. U.K. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
10.9.1. Solvents
10.9.2. Fuel Additives
10.9.3. Monomers
10.9.4. Chemical Intermediates
10.9.5. Others
10.10. U.K. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
10.10.1. Detergents
10.10.2. Cements
10.10.3. Fuels
10.10.4. Paints & Coatings
10.10.5. Plastics
10.10.6. Others
10.11. Italy Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
10.11.1. Solvents
10.11.2. Fuel Additives
10.11.3. Monomers
10.11.4. Chemical Intermediates
10.11.5. Others
10.12. Italy Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
10.12.1. Detergents
10.12.2. Cements
10.12.3. Fuels
10.12.4. Paints & Coatings
10.12.5. Plastics
10.12.6. Others
10.13. Russia & CIS Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
10.13.1. Solvents
10.13.2. Fuel Additives
10.13.3. Monomers
10.13.4. Chemical Intermediates
10.13.5. Others
10.14. Russia & CIS Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
10.14.1. Solvents
10.14.2. Fuel Additives
10.14.3. Monomers
10.14.4. Chemical Intermediates
10.14.5. Others
10.15. Rest of Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
10.15.1. Solvents
10.15.2. Fuel Additives
10.15.3. Monomers
10.15.4. Chemical Intermediates
10.15.5. Others
10.16. Rest of Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
10.16.1. Detergents
10.16.2. Cements
10.16.3. Fuels
10.16.4. Paints & Coatings
10.16.5. Plastics
10.16.6. Others
10.17. Europe Glycerol Carbonate Market Attractiveness Analysis
11. Asia Pacific Glycerol Carbonate Market Analysis
11.1. Key Findings
11.2. Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
11.2.1. Solvents
11.2.2. Fuel Additives
11.2.3. Monomers
11.2.4. Chemical Intermediates
11.2.5. Others
11.3. Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
11.3.1. Detergents
11.3.2. Cements
11.3.3. Fuels
11.3.4. Paints & Coatings
11.3.5. Plastics
11.3.6. Others
11.4. Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030
11.5. China Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
11.5.1. Solvents
11.5.2. Fuel Additives
11.5.3. Monomers
11.5.4. Chemical Intermediates
11.5.5. Others
11.6. China Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
11.6.1. Detergents
11.6.2. Cements
11.6.3. Fuels
11.6.4. Paints & Coatings
11.6.5. Plastics
11.6.6. Others
11.7. Japan Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
11.7.1. Solvents
11.7.2. Fuel Additives
11.7.3. Monomers
11.7.4. Chemical Intermediates
11.7.5. Others
11.8. Japan Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
11.8.1. Detergents
11.8.2. Cements
11.8.3. Fuels
11.8.4. Paints & Coatings
11.8.5. Plastics
11.8.6. Others
11.9. India Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
11.9.1. Solvents
11.9.2. Fuel Additives
11.9.3. Monomers
11.9.4. Chemical Intermediates
11.9.5. Others
11.10. India Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
11.10.1. Detergents
11.10.2. Cements
11.10.3. Fuels
11.10.4. Paints & Coatings
11.10.5. Plastics
11.10.6. Others
11.11. ASEAN Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
11.11.1. Solvents
11.11.2. Fuel Additives
11.11.3. Monomers
11.11.4. Chemical Intermediates
11.11.5. Others
11.12. ASEAN Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
11.12.1. Detergents
11.12.2. Cements
11.12.3. Fuels
11.12.4. Paints & Coatings
11.12.5. Plastics
11.12.6. Others
11.13. Rest of Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
11.13.1. Solvents
11.13.2. Fuel Additives
11.13.3. Monomers
11.13.4. Chemical Intermediates
11.13.5. Others
11.14. Rest of Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
11.14.1. Detergents
11.14.2. Cements
11.14.3. Fuels
11.14.4. Paints & Coatings
11.14.5. Plastics
11.14.6. Others
11.15. Asia Pacific Glycerol Carbonate Market Attractiveness Analysis
12. Latin America Glycerol Carbonate Market Analysis
12.1. Key Findings
12.2. Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
12.2.1. Solvents
12.2.2. Fuel Additives
12.2.3. Monomers
12.2.4. Chemical Intermediates
12.2.5. Others
12.3. Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
12.3.1. Detergents
12.3.2. Cements
12.3.3. Fuels
12.3.4. Paints & Coatings
12.3.5. Plastics
12.3.6. Others
12.4. Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030
12.5. Brazil Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
12.5.1. Solvents
12.5.2. Fuel Additives
12.5.3. Monomers
12.5.4. Chemical Intermediates
12.5.5. Others
12.6. Brazil Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
12.6.1. Detergents
12.6.2. Cements
12.6.3. Fuels
12.6.4. Paints & Coatings
12.6.5. Plastics
12.6.6. Others
12.7. Mexico Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
12.7.1. Solvents
12.7.2. Fuel Additives
12.7.3. Monomers
12.7.4. Chemical Intermediates
12.7.5. Others
12.8. Mexico Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
12.8.1. Detergents
12.8.2. Cements
12.8.3. Fuels
12.8.4. Paints & Coatings
12.8.5. Plastics
12.8.6. Others
12.9. Rest of Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
12.9.1. Solvents
12.9.2. Fuel Additives
12.9.3. Monomers
12.9.4. Chemical Intermediates
12.9.5. Others
12.10. Rest of Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
12.10.1. Detergents
12.10.2. Cements
12.10.3. Fuels
12.10.4. Paints & Coatings
12.10.5. Plastics
12.10.6. Others
12.11. Latin America Glycerol Carbonate Market Attractiveness Analysis
13. Middle East & Africa Glycerol Carbonate Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
13.2.1. Solvents
13.2.2. Fuel Additives
13.2.3. Monomers
13.2.4. Chemical Intermediates
13.2.5. Others
13.3. Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
13.3.1. Detergents
13.3.2. Cements
13.3.3. Fuels
13.3.4. Paints & Coatings
13.3.5. Plastics
13.3.6. Others
13.4. Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030
13.5. GCC Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
13.5.1. Solvents
13.5.2. Fuel Additives
13.5.3. Monomers
13.5.4. Chemical Intermediates
13.5.5. Others
13.6. GCC Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
13.6.1. Detergents
13.6.2. Cements
13.6.3. Fuels
13.6.4. Paints & Coatings
13.6.5. Plastics
13.6.6. Others
13.7. South Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
13.7.1. Solvents
13.7.2. Fuel Additives
13.7.3. Monomers
13.7.4. Chemical Intermediates
13.7.5. Others
13.8. South Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
13.8.1. Detergents
13.8.2. Cements
13.8.3. Fuels
13.8.4. Paints & Coatings
13.8.5. Plastics
13.8.6. Others
13.9. Rest of Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030
13.9.1. Solvents
13.9.2. Fuel Additives
13.9.3. Monomers
13.9.4. Chemical Intermediates
13.9.5. Others
13.10. Rest of Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030
13.10.1. Detergents
13.10.2. Cements
13.10.3. Fuels
13.10.4. Paints & Coatings
13.10.5. Plastics
13.10.6. Others
13.11. Middle East & Africa Glycerol Carbonate Market Attractiveness Analysis
14. Competition Landscape
14.1. Global Glycerol Carbonate Market Share Analysis, by Company, 2019
14.2. Competition Matrix
14.3. Application Mapping
14.4. Company Profiles
14.4.1. Huntsman International LLC
14.4.1.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.1.2. Business Overview
14.4.1.3. Products/Services, Key End-use Industries
14.4.1.4. Financial Overview
14.4.2. Eurisotop (Cambridge Isotope Laboratories, Inc. (CIL))
14.4.2.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.2.2. Business Overview
14.4.2.3. Products/Services, Key End-use Industries
14.4.3. UBE Industries India Private Ltd.
14.4.3.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.3.2. Business Overview
14.4.3.3. Products/Services, Key End-use Industries
14.4.4. Inkemia Green Chemicals Inc.
14.4.4.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.4.2. Business Overview
14.4.4.3. Products/Services, Key End-use Industries
14.4.5. TCI Chemicals (India) Pvt. Ltd.
14.4.5.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.5.2. Business Overview
14.4.5.3. Products/Services, Key End-use Industries
14.4.6. Carbone Scientific Co., Ltd.
14.4.6.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.6.2. Business Overview
14.4.6.3. Products/Services, Key End-use Industries
14.4.7. Acros Organics B.V.B.A. (Thermo Fisher Scientific Company)
14.4.7.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.7.2. Business Overview
14.4.7.3. Products/Services, Key End-use Industries
14.4.8. GLACONCHEMIE GmbH
14.4.8.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.8.2. Business Overview
14.4.8.3. Products/Services, Key End-use Industries
14.4.9. ANHUI MEISENBAO CHEMICAL CO., LTD.
14.4.9.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)
14.4.9.2. Business Overview
14.4.9.3. Products/Services, Key End-use Industries
15. Primary Research: Key Insights
16. Appendix
16.1. Research Methodology and Assumptions
List of Tables
Table 01 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 02 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 03 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 04 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 05 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 06 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 07 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 08 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 09 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 10 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 11 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 12 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 13 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 14 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 15 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 16 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 18 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 19 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 20 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 21 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 23 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 24 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 25 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 26 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 27 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 28 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 29 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 30 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
List of Figures
Figure 01 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, 2018–203
Figure 02 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Indication, 2019
Figure 03 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Drug Class, 2019
Figure 04 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Distribution Channel, 2019
Figure 05 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Region, 2019
Figure 06 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Indication, 2019 and 2030
Figure 07 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Indication, 2020–2030
Figure 08 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Multiple Sclerosis (MS), 2018–2030
Figure 09 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Alzheimer’s Disease, 2018–2030
Figure 10 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Parkinson's Disease, 2018–2030
Figure 11 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Acute Migraine, 2018–2030
Figure 12 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Autism, 2018–2030
Figure 13 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Narcolepsy, 2018–2030
Figure 14 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Amyotrophic Lateral Sclerosis (ALS), 2018–2030
Figure 15 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Attention Deficit Hyperactivity Disorder (ADHD), 2018–2030
Figure 16 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Spinal Muscular Atrophy, 2018–2030
Figure 17 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Tourette Syndrome, 2018–2030
Figure 18 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Huntington's disease, 2018–2030
Figure 19 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Others, 2018–2030
Figure 20 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 21 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 22 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Neuroprotective Agents, 2018–2030
Figure 23 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Neurotransmitter Agents, 2018–2030
Figure 24 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Biologics, 2018–2030
Figure 25 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Others, 2018–2030
Figure 26 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 27 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 28 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Hospital Pharmacies, 2018–2030
Figure 29 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Online Pharmacies, 2018–2030
Figure 30 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Retail Pharmacies, 2018–2030
Figure 31 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Region, 2019 and 2030
Figure 32 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Region, 2020–2030
Figure 33 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 34 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country, 2019 and 2030
Figure 35 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country, 2020–2030
Figure 36 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 37 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030
Figure 38 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 39 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 40 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 41 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 42 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 43 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030
Figure 44 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030
Figure 45 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 46 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030
Figure 47 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 48 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 49 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 50 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 51 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 52 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030
Figure 53 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030
Figure 54 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 55 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030
Figure 56 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 57 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 58 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 59 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 60 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 61 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030
Figure 62 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030
Figure 63 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 64 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030
Figure 65 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 66 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 67 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 68 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 69 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 70 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030
Figure 71 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030
Figure 72 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030
Figure 73 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030
Figure 74 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 75 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 76 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 77 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 78 Global Rare Neurodegenerative Disease Treatment Market Share Analysis, by Company, 2019
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Rare Neurodegenerative Disease Treatment Market
